| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $801.5M | -20.3% |
| Cost of Revenue | $530.2M | -22.2% |
| Gross Profit | $271.3M | -16.2% |
| R&D Expense | $185.9M | +12.2% |
| SG&A Expense | $59.8M | -6.2% |
| Operating Income | -$135.0M | -78.9% |
| Interest Expense | $3.3M | -29.2% |
| Pre-tax Income | -$133.1M | -96.5% |
| Income Tax | $299.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.8M | -53.8% |
| Accounts Receivable | $85.9M | -6.0% |
| Inventory | $120.7M | +13.6% |
| Current Assets | $339.2M | -29.7% |
| Total Assets | $543.7M | -43.8% |
| Current Liabilities | $356.3M | +27.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$125.1M | -280.8% |
| Capital Expenditures | $4.0M | +165.7% |
| Investing Cash Flow | $7.7M | -93.7% |
| Financing Cash Flow | -$929K | +99.0% |
| Free Cash Flow | -$129.2M | -275.7% |
| +2156.5% |
| Net Income | -$432.3M | -712.9% |
| EPS (Basic) | -$2.82 | -705.7% |
| EPS (Diluted) | -$2.82 | -705.7% |
| Total Liabilities |
| $392.0M |
| -4.9% |
| Stockholders' Equity | $151.7M | -72.7% |